Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04557384 |
| Title | A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | United States | Details | |
| Oncology Hematology West | Omaha | Nebraska | 68130 | United States | Details | |
| Levine Cancer Institute- Carolinas Medical Center | Charlotte | North Carolina | 28204 | United States | Details | |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | United States | Details | |
| Kindai University Hospital | Osaka Sayama-shi | Osaka | 589 8511 | Japan | Details |